These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 16478693)
1. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Xie FY; Woodle MC; Lu PY Drug Discov Today; 2006 Jan; 11(1-2):67-73. PubMed ID: 16478693 [TBL] [Abstract][Full Text] [Related]
2. Delivering small interfering RNA for novel therapeutics. Lu PY; Woodle MC Methods Mol Biol; 2008; 437():93-107. PubMed ID: 18369963 [TBL] [Abstract][Full Text] [Related]
3. In vivo application of RNA interference: from functional genomics to therapeutics. Lu PY; Xie F; Woodle MC Adv Genet; 2005; 54():117-42. PubMed ID: 16096010 [TBL] [Abstract][Full Text] [Related]
4. Efficient and targeted delivery of siRNA in vivo. Shim MS; Kwon YJ FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116 [TBL] [Abstract][Full Text] [Related]
5. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials. DeVincenzo JP Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462 [TBL] [Abstract][Full Text] [Related]
6. RNA interference: from gene silencing to gene-specific therapeutics. Leung RK; Whittaker PA Pharmacol Ther; 2005 Aug; 107(2):222-39. PubMed ID: 15908010 [TBL] [Abstract][Full Text] [Related]
7. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs. Dykxhoorn DM; Lieberman J Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561 [TBL] [Abstract][Full Text] [Related]
8. SiRNA delivery: challenges and role of carrier systems. Shegokar R; Al Shaal L; Mishra PR Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063 [TBL] [Abstract][Full Text] [Related]
9. Nonviral in vivo delivery of therapeutic small interfering RNAs. Aigner A Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447 [TBL] [Abstract][Full Text] [Related]
10. The design and exogenous delivery of siRNA for post-transcriptional gene silencing. Gilmore IR; Fox SP; Hollins AJ; Sohail M; Akhtar S J Drug Target; 2004 Jul; 12(6):315-40. PubMed ID: 15545082 [TBL] [Abstract][Full Text] [Related]
11. RNAi-based drug discovery and its application to therapeutics. Hokaiwado N; Takeshita F; Banas A; Ochiya T IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962 [TBL] [Abstract][Full Text] [Related]
12. Cellular delivery in vivo of siRNA-based therapeutics. Aigner A Curr Pharm Des; 2008; 14(34):3603-19. PubMed ID: 19075737 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of RNA interference against cancer. Takeshita F; Ochiya T Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503 [TBL] [Abstract][Full Text] [Related]
14. shRNA and siRNA delivery to the brain. Pardridge WM Adv Drug Deliv Rev; 2007 Mar; 59(2-3):141-52. PubMed ID: 17434235 [TBL] [Abstract][Full Text] [Related]
15. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588 [TBL] [Abstract][Full Text] [Related]
16. Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. Kumar LD; Clarke AR Adv Drug Deliv Rev; 2007 Mar; 59(2-3):87-100. PubMed ID: 17434644 [TBL] [Abstract][Full Text] [Related]
17. Molecular design and delivery of siRNA. Inoue A; Sawata SY; Taira K J Drug Target; 2006; 14(7):448-55. PubMed ID: 17062391 [TBL] [Abstract][Full Text] [Related]
18. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting. Plane G IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-based delivery system for application of siRNA in vivo. Wang Y; Li Z; Han Y; Liang LH; Ji A Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287 [TBL] [Abstract][Full Text] [Related]